somatuline 120mg for s.c. injection [pancreatic/gastrointestinal neuroendocrine tumors] (ソマチュリン皮下注120mg[膵・消化管神経内分泌腫瘍])
teijin pharma limited - lanreotide acetate - injecion
somatuline 120mg for s.c. injection [thyroid-stimulating hormone-secreting pituitary tumor] (ソマチュリン皮下注120mg[甲状腺刺激ホルモン産生下垂体腫瘍])
teijin pharma limited - lanreotide acetate - injection
somatuline 120mg for s.c. injection[acromegaly, pituitary gigantism] (ソマチュリン皮下注120mg[先端巨大症・下垂体性巨人症])
teijin pharma limited - lanreotide acetate - injection
somatuline 60mg for s.c. injection [thyroid-stimulating hormone-secreting pituitary tumor] (ソマチュリン皮下注60mg[甲状腺刺激ホルモン産生下垂体腫瘍])
teijin pharma limited - lanreotide acetate - injection
somatuline 60mg for s.c. injection[acromegaly, pituitary gigantism] (ソマチュリン皮下注60mg[先端巨大症・下垂体性巨人症])
teijin pharma limited - lanreotide acetate - injection
somatuline 90mg for s.c. injection [thyroid-stimulating hormone-secreting pituitary tumor] (ソマチュリン皮下注90mg[甲状腺刺激ホルモン産生下垂体腫瘍])
teijin pharma limited - lanreotide acetate - injection
somatuline 90mg for s.c. injection[acromegaly, pituitary gigantism] (ソマチュリン皮下注90mg[先端巨大症・下垂体性巨人症])
teijin pharma limited - lanreotide acetate - injection
exubera
pfizer limited - insulin human - diabetes mellitus - drugs used in diabetes - exubera is indicated for the treatment of adult patients with type 2 diabetes mellitus notadequately controlled with oral antidiabetic agents and requiring insulin therapy.exubera is also indicated for the treatment of adult patients with type 1 diabetes mellitus, inaddition to long or intermediate acting subcutaneous insulin, for whom the potential benefits ofadding inhaled insulin outweigh the potential safety concerns (see section 4.4).
levemir® flexpen® 100uml 3ml
novo nordisk pharma (singapore) pte ltd - insulin detemir - injection, solution - 14.2 mg/ml - insulin detemir 14.2 mg/ml
novomix 30 flexpen injection 100 uml
novo nordisk pharma (singapore) pte ltd - protamine-crystallised insulin aspart; soluble insulin aspart - injection - 70.00% - protamine-crystallised insulin aspart 70%; soluble insulin aspart 30%